It has been an accepted hypothesis that most of the anti-tumor responses are mediated by CD8+ T cells and CD4+ T cells are restricted either to help CD8+ T cells for effective cytotoxicity [4,5] or prime dendritic cells (DC) to enhance the response of CD8+ T cells [6,7]. This evidence concerns the gene CD8A and neoplasm.